StageBio

StageBio, founded in 2016, is a specialized histopathology CRO serving the biopharma and medical device industries. It offers an integrated suite of services including necropsy, histology, pathology, archiving, and niche expertise in areas like neuropathology and ocular histopathology. The company operates globally with locations in the US and Germany, leveraging a team of over 20 board-certified pathologists to support thousands of studies. As a private, services-focused company, it generates revenue by providing critical, regulatory-compliant data generation and storage solutions.

Integrated GLP-compliant histopathology service platform including necropsy, histology, digital pathology, IHC/IF/ISH, specialized pathology evaluation (neuro, ocular, medical device), and secure specimen archiving/biorepository services.

StageBio competes with large, full-service preclinical CROs (e.g., Charles River, Labcorp) that have in-house pathology departments, as well as other specialized histopathology labs and academic core facilities. Its differentiation lies in its exclusive focus on histopathology, deep niche expertise, and integrated archiving solutions.